[New analogues of methotrexate]
- PMID: 1444480
[New analogues of methotrexate]
Abstract
New antifolate antimetabolites are currently developed and three analogues of methotrexate (MTX) (Trimetrexate, Edatrexate, TNP-351) are undergoing clinical trials in Japan. Trimetrexate characteristically enters cells primarily by passive transport, which is different from the mechanism of MTX. The increased therapeutic efficacy of Edatrexate is expected, because of the higher concentration of polyglutamates than MTX in tumor cells. TNP-351 is a novel antifolate, which has a different chemical structure from other antifolates. The current state of clinical trials of three antifolates and the indications for chemotherapy of lung cancer are reviewed.
Similar articles
-
[Development of antimetabolites, II].Gan To Kagaku Ryoho. 1993 Jan;20(1):19-26. Gan To Kagaku Ryoho. 1993. PMID: 8422184 Review. Japanese.
-
Phase I and pharmacokinetic study of 10-propargyl-10-deazaaminopterin, a new antifolate.Clin Cancer Res. 2000 Sep;6(9):3493-8. Clin Cancer Res. 2000. PMID: 10999734 Clinical Trial.
-
Cytotoxicity, uptake, polyglutamate formation, and antileukemic effects of 8-deaza analogues of methotrexate and aminopterin in mice.Cancer Res. 1988 Mar 15;48(6):1481-8. Cancer Res. 1988. PMID: 2449950
-
Ex vivo activity of methotrexate versus novel antifolate inhibitors of dihydrofolate reductase and thymidylate synthase against childhood leukemia cells.Clin Cancer Res. 1998 Oct;4(10):2399-410. Clin Cancer Res. 1998. PMID: 9796971
-
Antifolate analogs: mechanism of action, analytical methodology, and clinical efficacy.Ther Drug Monit. 1993 Dec;15(6):521-6. Ther Drug Monit. 1993. PMID: 8122287 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical